Respirovirus Infections
-
Subject Areas on Research
- Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease.
- Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma.
- Human parainfluenza virus giant cell pneumonia following cord blood transplant associated with pulmonary alveolar proteinosis.
- Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection.
- Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis.
- Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada.
- Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience.
- Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
- Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.